CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
(SOC) in participants with untreated T4N0 or Stage III (resectable), defective mismatch repair/ microsatellite instability high (dMMR/MSI-H) colon...
Phase 3
Fort Lauderdale, Florida, United States and 262 other locations
and pembrolizumab) given together for the treatment of colorectal cancer that:* is metastatic (spread to other parts of the body);* has the ...
Phase 2
Miami Beach, Florida, United States and 61 other locations
the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon...
Phase 2, Phase 3
Pembroke Pines, Florida, United States and 1076 other locations
its effectiveness in reducing the stoma creation rate and by comparing the rate of major complications to current standard of care for rectal cancer...
Weston, Florida, United States and 8 other locations
A Phase 1 dose escalation study in patients with advanced solid tumors harboring KRAS G12C mutation to determine the maximum tolerated dose and recom...
Phase 1
Plantation, Florida, United States of America and 13 other locations
This study is designed to characterize the safety, tolerability, and anti-tumor activity of MDX2001 in patients with advanced solid tumors.
Phase 1, Phase 2
Miami, Florida, United States and 5 other locations
The goal of this clinical trial is to determine the safety and efficacy of IP-001 for intratumoral injection administration following thermal ablatio...
Phase 1, Phase 2
Coral Gables, Florida, United States and 15 other locations
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of escalating doses of RMC-6291 (KRAS G12C(ON) inhibitor...
Phase 1
Miami, Florida, United States and 63 other locations
The purpose of this research is to identify individuals overdue for colon cancer screening and send them a reminder to complete the...
Miami, Florida, United States
chemotherapy and bevacizumab with or without INCA33890 in the first-line treatment of metastatic microsatellite stable colorectal cancer....
Phase 3
Miami, Florida, United States and 256 other locations
Clinical trials
Research sites
Resources
Legal